Strata Skin Sciences Income from Continuous Operations 2010-2025 | SSKN
Strata Skin Sciences income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Strata Skin Sciences Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-10 |
| 2023 | $-11 |
| 2022 | $-6 |
| 2021 | $-3 |
| 2020 | $-4 |
| 2019 | $-4 |
| 2018 | $-4 |
| 2017 | $-22 |
| 2016 | $-3 |
| 2015 | $-25 |
| 2014 | $-14 |
| 2013 | $-26 |
| 2012 | $-23 |
| 2011 | $-20 |
| 2010 | $-20 |
| 2009 | $-18 |
| Strata Skin Sciences Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-2 |
| 2025-03-31 | $-2 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $0 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-4 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $0 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $-2 |
| 2020-12-31 | $0 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $0 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-14 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-2 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $0 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-8 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $1 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-7 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-5 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-5 |
| 2011-09-30 | $-6 |
| 2011-06-30 | $-5 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-5 |
| 2010-09-30 | $-5 |
| 2010-06-30 | $-5 |
| 2010-03-31 | $-5 |
| 2009-12-31 | $-6 |
| 2009-09-30 | $-5 |
| 2009-06-30 | $-4 |
| 2009-03-31 | $-4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.976B | 58.72 |
| Doximity (DOCS) | United States | $12.734B | 56.66 |
| Tempus AI (TEM) | United States | $12.722B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.947B | 81.50 |
| IRhythm Technologies (IRTC) | United States | $5.455B | 0.00 |
| Hinge Health (HNGE) | United States | $4.531B | 0.00 |
| Heartflow (HTFL) | $2.821B | 0.00 | |
| Inspire Medical Systems (INSP) | United States | $2.730B | 40.13 |
| Privia Health (PRVA) | United States | $2.669B | 197.73 |
| Phreesia (PHR) | United States | $1.904B | 0.00 |
| Enovis (ENOV) | United States | $1.773B | 9.37 |
| 10x Genomics (TXG) | United States | $1.745B | 0.00 |
| Omnicell (OMCL) | United States | $1.526B | 29.41 |
| Schrodinger (SDGR) | United States | $1.457B | 0.00 |
| Azenta (AZTA) | United States | $1.384B | 60.40 |
| Clover Health Investments (CLOV) | United States | $1.379B | 0.00 |
| Claritev (CTEV) | United States | $1.184B | 0.00 |
| Evolent Health (EVH) | United States | $1.130B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.542B | 0.00 |
| Veradigm (MDRX) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.489B | 0.00 |
| Talkspace (TALK) | United States | $0.454B | 135.50 |
| Butterfly Network (BFLY) | United States | $0.395B | 0.00 |
| Carlsmed (CARL) | United States | $0.369B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 52.95 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| Outset Medical (OM) | United States | $0.248B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.225B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.210B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.157B | 7.13 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.085B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.040B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| PROFUSA (PFSA) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |